Literature DB >> 1958696

L-carnitine uptake in differentiating human cultured muscle.

A Martinuzzi1, L Vergani, M Rosa, C Angelini.   

Abstract

We studied carnitine uptake in human skeletal muscle growing in culture for up to 30 days, and correlated it to the degree of muscle differentiation revealed by myotube formation and muscle-specific creatine-kinase isozyme accumulation. In our study carnitine uptake was a saturable specific process with two distinct components: a high affinity uptake at carnitine concentration between 0.5 and 10 microM and a low affinity uptake at carnitine concentration between 25 and 200 microM. High affinity uptake (Km 4.17-5.50 microM, Vmax 11.78-19.6 pmol/h per mg protein) did not change during muscle maturation in culture. Low affinity uptake showed significant changes in Km and Vmax in the various stages of muscle differentiation. Our studies suggest the existence of a muscle-specific system, operating at physiological carnitine concentration, which gradually develops during muscle maturation in culture. We hypothesize that a defect of the low affinity muscle-specific uptake might be the cause of the primary muscle carnitine deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958696     DOI: 10.1016/0167-4889(91)90102-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

Review 2.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

3.  Ultrastructural aspects of the effects of L-carnitine administration on epithelial cells in the aging rat tongue.

Authors:  D Barlagiannis; Em Dietrich; V Papaliagkas; S Makri; A Toskas; T Papamitsou
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

4.  A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.

Authors:  Gianfranco Fornasini; Richard N Upton; Allan M Evans
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.